London Daily

Focus on the big picture.
Friday, Aug 08, 2025

UK biotech hails milestone in hunt for jab to combat  peanut allergies

UK biotech hails milestone in hunt for jab to combat peanut allergies

ABRITISH biotech spun out from SmithKline Beecham in the 1990s is on the brink of a breakthrough in the hunt for the “holy grail” of allergy research - a vaccine for peanut allergy sufferers.

AIM-listed Allergy Therapeutics, based in Worthing, is seeking permission with the US Food and Drug Administration regulator to begin human trials of its short-course jab next year following the publication of results from tests run in collaboration with London’s Imperial College.

The treatment uses a plant-based Cucumber Mosaic Virus engineered to display the key allergen which triggers what can be a potentially life-threatening anaphylactic over-reaction in sufferers.

These virus-like particles (VLPs) train the patient’s immune system to produce protective antibodies against the allergen, in the same way traditional vaccinations protect against invading viruses, which dampen down the response.

Allergy Therapeutics


Results from the Imperial study showed a 24-fold reduction in the activation of infection-fighting white blood cells (basophils) and histamine release after blood samples from allergy patients were challenged with the vaccine.

A short-course treatment of shots would pave the way for a major shift in how one of the most common types of food allergies - whose symptoms can range from mild to severe and life-threatening - is managed.

Around 2% of children in the UK are affected by the condition, of whom only around a fifth outgrow it by the time they reach school age.

The prevalence of peanut allergy doubled between 2005 and 2015 and it is the most common cause of severe and fatal food-induced anaphylactic reactions in the US.

Allergy Therapeutics believes successful human trials will open up opportunities to enter the $8 billion worldwide food allergy market.

Early research is also underway to establish its potential application in oncology and immune conditions such as asthma and psoriasis.

The immunotherapy specialist was formed in 1999, spun out of GSK’s predecessor, and last year recorded sales of £78 million for its portfolio of therapies for mostly pollen-related allergies.

Manuel Llobet, CEO of Allergy Therapeutics, said: “We are pleased to have reached this important milestone in the development of our ground-breaking and disruptive vaccine candidate, VLP Peanut.

“Through our collaboration with Imperial College London and the dedication of our clinical and R&D teams at Allergy Therapeutics, we are another step closer to offering a potentially transformative treatment option for one of the most dangerous allergies.

“I am proud of the work we do in helping to transform patients’ lives and look forward to our upcoming Investigational New Drug submission at the end of this year and expected initiation of our Phase I trial in 2022.”

Shares in Allergy Therapeutics were up 5.59% at 28.35p today.

Newsletter

Related Articles

0:00
0:00
Close
British Labour Government Utilizes Counter-Terrorism Tools for Social Media Monitoring Against Legitimate Critics
OpenAI Launches GPT‑5, Its Most Advanced AI Model Yet
Embarrassment in Britain: Homelessness Minister Evicted Tenants and Forced to Resign
President Trump nominated Stephen Miran, his top economic adviser and a critic of the Federal Reserve, to temporarily fill an open Fed seat
The AI-Powered Education Revolution: Market Potential and Transformative Impact
Chikungunya Virus Outbreak in Southern China: Over 7,000 Hospitalized
French wine makers have seen catastrophic damage to vines that were almost ready to be harvested after the worst fires in more than 70 years burned through the south of the country
US Lawmaker Probes Intel CEO’s China Ties Amid National Security Concerns
Brazilian President Lula says he’ll contact the leaders of BRICS states to propose a unified response to U.S. tariffs
Trump Open to Meeting Putin as Soon as Next Week, with Possible Trilateral Summit Including Zelenskiy
Katy Perry and Justin Trudeau spark dating rumors, joining high stakes world of celeb-politician romances
US envoy Steve Witkoff arrived in Moscow to seek a breakthrough in the Ukraine war ahead of President Trump’s peace deadline
WhatsApp Deletes 6.8 Million Scam Accounts Amid Rising Global Fraud
Nine people have been hospitalized and dozens of salmonella cases have been reported after an outbreak of infections linked to certain brands of pistachios and pistachio-containing products, according to the Public Health Agency of Canada
Karol Nawrocki Inaugurated as Poland’s President, Setting Stage for Clash with Tusk Government
Trump Signals JD Vance as ‘Most Likely’ MAGA Successor for 2028
US Charges Two Chinese Nationals for Illegal Nvidia AI Chip Exports
Texas Residents Face Water Restrictions While AI Data Centers Consume Millions of Gallons
U.S. Tariff Policy Triggers Market Volatility Amid Growing Global Trade Tensions
Tariffs, AI, and the Shifting U.S. Macro Landscape: Navigating a New Economic Regime
Representative Greene Urges H-1B Visa Cuts Amid U.S.-India Trade Tensions
U.S. House Committee Subpoenas Clintons and Senior Officials in Epstein Investigation
Sydney Sweeney Registered as Republican as Controversial American Eagle Ad Sparks Debate
Trump Accuses Major Banks of Politically Motivated Account Denials and Prepares Executive Order
TikTok Removes Huda Kattan Video Over Anti-Israel Conspiracy Claims
Trump Threatens Tariffs on India Over Russian Oil Imports
German Finance Minister Criticizes Trump’s Attacks on Institutions
U.S. Proposes Visa Bond of Up to $15,000 for Some Applicants
U.S. Farmers Increase Lobbying Amid Immigration Crackdown
Elon Musk Receives $23.7 Billion Tesla Stock Award
Texas House Paralyzed After Democrats Walk Out Over Redistricting
Mexican Cartels Complicate Sheinbaum’s U.S. Security Talks
Mark Zuckerberg Declares War on the iPhone
India Rejects U.S. Tariff Threat, Defends Russian Oil Purchases
United States Establishes Strategic Bitcoin Reserve and Digital Asset Stockpile
Thousands of Private ChatGPT Conversations Accidentally Indexed by Google
China Tightens Mineral Controls, Curtailing Critical Inputs for Western Defence Contractors
OpenAI’s Bold Bet: Teaching AI to Think, Not Just Chat
Tesla Seeks Shareholder Approval for $29 Billion Compensation Package for Elon Musk
Nvidia is cutting prices on its RTX 50-series graphics cards after sales slowed and inventories piled up
Ghislaine Maxwell Transferred to Minimum-Security Prison Amid Ongoing DOJ Discussions
U.S. Tariffs Surge to Highest Levels in Nearly a Century Under Second Trump Term
Matt Taibbi Slams Media for Role in Russiagate Narrative
Pilots Call for Mental Health Support Without Stigma
All Five Trapped Miners Found Dead After El Teniente Mine Collapse
Ong Beng Seng Pleads Guilty in Corruption Case Linked to Former Singapore Transport Minister
BP’s Largest Oil and Gas Find in 25 Years Uncovered Offshore Brazil
Italy Fines Shein One Million Euros for Misleading Sustainability Claims
JPMorgan and Coinbase Unveil Partnership to Let Chase Cardholders Buy Crypto Directly
Declassified Annex Links Soros‑Affiliated Officials and Clinton Campaign to ‘Russiagate’ Narrative
×